Optimizing antigen preparation for oxalyl-CoA decarboxylase enzyme diagnostic kit and ELISA system cutoff determination
Urolithiasis · 2024
DOI: 10.1007/s00240-024-01635-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urolithiasis, 2024. Verfasst von Davood Khavari Ardestani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Urology and Nephrology Research Center (UNRC), Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran. Hauptthemen laut MEDLINE: Enzyme-Linked Immunosorbent Assay, Carboxy-Lyases. Die Arbeit nennt 15 Literaturangaben. Gefördert von: The present study was carried out in the Cellular & Molecular Biology Research Center of Shahid Beheshti University of Medical Sciences, Tehran, Iran. and supp….
Abstract (Originalsprache)
The prevalence of kidney stone disease is increasing globally, with calcium oxalate stones being the most common type. Oxalyl-CoA decarboxylase (OXC), an enzyme produced by the gut bacterium Oxalobacter formigenes, plays a crucial role in oxalate metabolism. Deficiencies in OXC activity can lead to the accumulation of oxalate, contributing to kidney stone formation. This study aimed to develop a reliable diagnostic assay for OXC by optimizing antigen production and establishing a cutoff value for an enzyme-linked immunosorbent assay (ELISA). We cloned, expressed, and purified recombinant OXC protein in Escherichia coli BL21(DE3), and generated specific polyclonal antibodies in rabbits. The ELISA system was optimized and validated using serum samples from 40 healthy individuals and 6 patients with oxalate-related disorders. The cutoff value was determined using the formula (M + 2SD), where (M) is the mean and (SD) is the standard deviation of the healthy sample results. The calculated cutoff value of 0.656750 effectively distinguished between healthy and affected individuals, with a sensitivity of 97.5% and a specificity of 83.3%. These findings provide a valuable tool for the early detection and management of oxalate-related disorders, with significant implications for clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology and Nephrology Research Center (UNRC), Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
- Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1968917313, Iran.
- Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. khavarid@gmail.com.
- Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1968917313, Iran. khavarid@gmail.com.
Förderung
- The present study was carried out in the Cellular & Molecular Biology Research Center of Shahid Beheshti University of Medical Sciences, Tehran, Iran. and supp…
Zitieren
APA
Ardestani, D. K., Basiri, A., Bandehpour, M., Abdi-Ghavidel, A., & Kazemi, B. (2024). Optimizing antigen preparation for oxalyl-CoA decarboxylase enzyme diagnostic kit and ELISA system cutoff determination. Urolithiasis. https://doi.org/10.1007/s00240-024-01635-7
Vancouver
Ardestani DK, Basiri A, Bandehpour M, Abdi-Ghavidel A, Kazemi B. Optimizing antigen preparation for oxalyl-CoA decarboxylase enzyme diagnostic kit and ELISA system cutoff determination. Urolithiasis. 2024. doi:10.1007/s00240-024-01635-7
BibTeX
@article{Ardestani2024,
author = {Ardestani, Davood Khavari and Basiri, Abbas and Bandehpour, Mojgan and Abdi-Ghavidel, Afshin and Kazemi, Bahram},
title = {Optimizing antigen preparation for oxalyl-CoA decarboxylase enzyme diagnostic kit and ELISA system cutoff determination},
journal = {Urolithiasis},
year = {2024},
doi = {10.1007/s00240-024-01635-7}
}
EUVIMED